Voya Investment Management LLC Has $2.70 Million Holdings in Surgery Partners, Inc. (NASDAQ:SGRY)

Voya Investment Management LLC increased its position in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 411.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 127,707 shares of the company's stock after purchasing an additional 102,759 shares during the period. Voya Investment Management LLC owned approximately 0.10% of Surgery Partners worth $2,704,000 at the end of the most recent quarter.

A number of other hedge funds also recently added to or reduced their stakes in the business. KBC Group NV grew its stake in shares of Surgery Partners by 66.1% in the fourth quarter. KBC Group NV now owns 3,962 shares of the company's stock worth $84,000 after acquiring an additional 1,577 shares in the last quarter. MeadowBrook Investment Advisors LLC increased its position in Surgery Partners by 16.6% in the 4th quarter. MeadowBrook Investment Advisors LLC now owns 10,280 shares of the company's stock valued at $218,000 after acquiring an additional 1,460 shares during the period. Tower Research Capital LLC TRC raised its holdings in Surgery Partners by 279.3% during the 4th quarter. Tower Research Capital LLC TRC now owns 10,762 shares of the company's stock worth $228,000 after buying an additional 7,925 shares during the period. Empowered Funds LLC acquired a new position in Surgery Partners during the fourth quarter worth $245,000. Finally, KLP Kapitalforvaltning AS bought a new stake in shares of Surgery Partners during the fourth quarter valued at approximately $273,000.

Insider Buying and Selling

In other Surgery Partners news, CFO David T. Doherty sold 13,641 shares of Surgery Partners stock in a transaction dated Friday, February 7th. The shares were sold at an average price of $25.61, for a total transaction of $349,346.01. Following the completion of the sale, the chief financial officer now directly owns 108,862 shares in the company, valued at $2,787,955.82. This trade represents a 11.14 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Jason Eric Evans sold 26,520 shares of the company's stock in a transaction dated Friday, February 7th. The shares were sold at an average price of $25.65, for a total transaction of $680,238.00. Following the completion of the sale, the chief executive officer now directly owns 560,698 shares of the company's stock, valued at $14,381,903.70. The trade was a 4.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 106,365 shares of company stock worth $2,711,255. Insiders own 2.30% of the company's stock.

Analyst Ratings Changes

A number of analysts recently issued reports on SGRY shares. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $35.00 target price on shares of Surgery Partners in a research report on Tuesday, March 25th. Benchmark reissued a "buy" rating and issued a $35.00 price target on shares of Surgery Partners in a research note on Monday, April 21st. Finally, Macquarie dropped their price target on shares of Surgery Partners from $34.00 to $33.00 and set an "outperform" rating on the stock in a research report on Tuesday, March 11th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $34.75.

Surgery Partners Stock Down 0.7 %

NASDAQ SGRY traded down $0.17 during trading on Thursday, hitting $22.99. The stock had a trading volume of 240,755 shares, compared to its average volume of 1,085,308. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.66 and a current ratio of 1.80. The company's 50-day moving average price is $22.67 and its two-hundred day moving average price is $23.60. Surgery Partners, Inc. has a 12 month low of $19.50 and a 12 month high of $33.97. The company has a market capitalization of $2.95 billion, a PE ratio of -47.90, a P/E/G ratio of 19.21 and a beta of 1.96.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last posted its quarterly earnings results on Monday, March 3rd. The company reported $0.39 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.01. The company had revenue of $864.40 million during the quarter, compared to analyst estimates of $828.09 million. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. As a group, sell-side analysts forecast that Surgery Partners, Inc. will post 0.67 EPS for the current year.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.